Winton Group’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
VI
MF
FLAM
AAM
KLCMU
RSCM
Winton Group's XENT Position: Q4 2021 in Review
Winton Group sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 23,760 shares — an estimated $646K sold.
Winton Group first reported a position in XENT in Q1 2018 and held it in 11 quarters. The position peaked at $1.42M in Q3 2020. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.
- Winton Group reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
- Winton Group sold 23,760 Intersect ENT, Inc shares in Q4 2021, an estimated $646K.
- Winton Group first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 11 quarters.
- Winton Group's Intersect ENT, Inc position peaked at $1.42M in Q3 2020.
- 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.
Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.